UnitedHealth Group Inc. (NYSE:UNH) was downgraded by Vetr from a “buy” rating to a “hold” rating in a report released on Tuesday. They presently have a $144.66 price target on the healthcare conglomerate’s stock. Vetr‘s price objective would suggest a potential upside of 0.89% from the company’s current price.

A number of other brokerages have also weighed in on UNH. Wedbush reaffirmed an “outperform” rating and set a $165.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 19th. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target for the company in a research report on Friday, July 22nd. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 21st. Citigroup Inc. boosted their price target on UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a research report on Wednesday, July 20th. Finally, Credit Suisse Group AG reissued a “buy” rating and issued a $148.00 price target on shares of UnitedHealth Group in a research report on Wednesday, June 29th. Two equities research analysts have rated the stock with a hold rating, twenty-four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $154.95.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH) traded up 6.90% on Tuesday, reaching $143.39. The company’s stock had a trading volume of 10,141,914 shares. UnitedHealth Group has a 1-year low of $107.51 and a 1-year high of $144.48. The firm’s 50 day moving average price is $137.12 and its 200-day moving average price is $136.75. The company has a market capitalization of $136.56 billion, a price-to-earnings ratio of 22.44 and a beta of 0.57.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.08 by $0.09. The business earned $46.30 billion during the quarter, compared to analyst estimates of $46.09 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. UnitedHealth Group’s revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.77 EPS. Equities analysts forecast that UnitedHealth Group will post $7.90 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were issued a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 1.74%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio is currently 39.12%.

In related news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.65% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Van Hulzen Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth about $104,000. Archford Capital Strategies LLC raised its position in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares during the last quarter. Hanson McClain Inc. raised its position in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $126,000 after buying an additional 4 shares during the last quarter. Howe & Rusling Inc. raised its position in shares of UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock worth $130,000 after buying an additional 40 shares during the last quarter. Finally, Parkside Financial Bank & Trust raised its position in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares during the last quarter. Hedge funds and other institutional investors own 85.80% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.